Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.
Vernieri F, Brunelli N, Guerzoni S, Iannone LF, Baraldi C, Rao R, Schiano di Cola F, Ornello R, Cevoli S, Lovati C, Albanese M, Perrotta A, Cetta I, Rossi SS, Taranta V, Filippi M, Geppetti P, Sacco S, Altamura C.
Vernieri F, et al. Among authors: iannone lf.
J Neurol. 2023 Nov;270(11):5436-5448. doi: 10.1007/s00415-023-11872-2. Epub 2023 Jul 19.
J Neurol. 2023.
PMID: 37468621